Results
|
|
81.
|
|
|
|
82.
|
|
|
|
83.
|
|
|
|
84.
|
|
|
|
85.
|
|
|
|
86.
|
|
|
|
87.
|
|
|
|
88.
|
|
|
|
89.
|
|
|
|
90.
|
In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons. [electronic resource] by
- Hidvégi, T
- Schmidt, B
- Varga, L
- Dervaderics, M
- Lantos, A
- Gönczi, Z
- Barok, J
- Otos, M
- Kirschfink, M
- Späth, P
Producer: 19961023
In:
Immunology letters vol. 48
Availability: No items available.
|
|
|
91.
|
|
|
|
92.
|
|
|
|
93.
|
C1 inhibitor prevents capillary leakage after thermal trauma. [electronic resource] by
- Radke, A
- Mottaghy, K
- Goldmann, C
- Khorram-Sefat, R
- Kovacs, B
- Janssen, A
- Klosterhalfen, B
- Hafemann, B
- Pallua, N
- Kirschfink, M
Producer: 20001011
In:
Critical care medicine vol. 28
Availability: No items available.
|
|
|
94.
|
Inherited neuroaxonal dystrophy in C6 deficient rabbits. [electronic resource] by
- Giannini, C
- Monaco, S
- Kirschfink, M
- Rother, K O
- Lorbacher de Ruiz, H
- Nardelli, E
- Bonetti, B
- Salviati, A
- Zanette, G P
- Rizzuto, N
Producer: 19921006
In:
Journal of neuropathology and experimental neurology vol. 51
Availability: No items available.
|
|
|
95.
|
Inverse correlation between IgG-antihinge region and antierythrocyte autoantibody in chronic benign and malignant cold agglutination. [electronic resource] by
- Terness, P
- Kirschfink, M
- Navolan, D
- Moroder, L
- Siedler, F
- Drugarin, D
- Schneider, F
- Dufter, C
- Kohl, I
- Welschof, M
- Opelz, G
- Roelcke, D
Producer: 19970724
In:
Journal of clinical immunology vol. 17
Availability: No items available.
|
|
|
96.
|
|
|
|
97.
|
|
|
|
98.
|
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). [electronic resource] by
- Licht, C
- Heinen, S
- Józsi, M
- Löschmann, I
- Saunders, R E
- Perkins, S J
- Waldherr, R
- Skerka, C
- Kirschfink, M
- Hoppe, B
- Zipfel, P F
Producer: 20060823
In:
Kidney international vol. 70
Availability: No items available.
|
|
|
99.
|
|
|
|
100.
|
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders. [electronic resource] by
- Wehling, C
- Amon, O
- Bommer, M
- Hoppe, B
- Kentouche, K
- Schalk, G
- Weimer, R
- Wiesener, M
- Hohenstein, B
- Tönshoff, B
- Büscher, R
- Fehrenbach, H
- Gök, Ö-N
- Kirschfink, M
Producer: 20170509
In:
Clinical and experimental immunology vol. 187
Availability: No items available.
|